公司資料
Cardax Pharma 股價、新聞與催化劑
- 股票代碼:
- CDXI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for CDXI.
公司概覽
業務概覽
Cardax was a specialty biopharmaceutical company focused on inflammation-related products and nutraceutical or therapeutic concepts. Its story was built around a narrow anti-inflammatory thesis.
所在地與產業分類
Cardax is headquartered in the United States and listed on NASDAQ. It sits in specialty biopharma.
商業模式特徵
The company depended on commercial or development progress, capital management, and the ability to maintain a focused product set. Investors historically watched revenue and strategic repositioning.
生技產業定位
Cardax belongs to the historical specialty-inflammation bucket. It is a small company where execution and survival mattered as much as the science.
未來催化劑
- Cardax is a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。